[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100633191":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":49,"collaborators":20,"id":53,"slug":20,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":20,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":20,"maxAge":60,"enrollmentInfo":61,"targetDuration":20,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":20,"overallStatus":29,"whyStopped":20,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Tanta University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Study group","EXPERIMENTAL","Children with refractory nocturnal enuresis or dysfunctional voiding.",[13],"Drug: Botulinium Toxin-A",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","Botulinium Toxin-A","Patients will be injected with botulinium toxin-A",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Ahmad M Shalaby, MBBCH","CONTACT","00201021847979","Ahmed.m.shalaby97@gmail.com",[28],{"facility":5,"status":29,"city":30,"state":31,"zip":32,"country":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"RECRUITING","Tanta","El-Gharbia","31527","Egypt",{"type":35,"coordinates":36},"Point",[37,38],31.00192,30.78847,{"lat":38,"lon":37},[41,42,45,47],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"name":43,"role":44,"phone":20,"phoneExt":20,"email":20},"Osama M ElGamal, MD","SUB_INVESTIGATOR",{"name":46,"role":44,"phone":20,"phoneExt":20,"email":20},"Mohamed A Omar, MD",{"name":48,"role":44,"phone":20,"phoneExt":20,"email":20},"Mohamed I Elmaadawy, MD",{"type":50,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Ahmad Mohamed Elsaied Shalaby","Resident of Urology, Tanta University, Tanta, Egypt","100633191",false,"NCT07523477","Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis","Evaluation of Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis","Inclusion Criteria:\n\n* Children \\\u003C 18 years.\n* Both sexes.\n* Patients with refractory nocturnal enuresis or dysfunctional voiding who are not responding to the traditional treatment.\n\nExclusion Criteria:\n\n* Bleeding disorders.\n* Neuromusclar disorder(e.g.,Myasthenia gravis).\n* Patients who are not fit for anaesthesia.\n* Active urinary tract infection (UTI).","ALL","18 Years",{"count":62,"type":63},64,"ESTIMATED","INTERVENTIONAL",[66],"NA","The aim of this study is to evaluate the outcome of botulinum toxin A (BTX-A) injection for management of children with :\n\nA-Dysfunctional voiding who are not responding to traditional treatment. B-Refractory nocturnal enuresis.",[69,17,70,71,72],"Local Injection","Children","Dysfunctional Voiding","Refractory Nocturnal Eneuresis","2026-04-05",{"date":75,"type":76},"2026-04-13","ACTUAL",{"date":78,"type":76},"2025-06-01",{"date":80,"type":63},"2026-12-01",{"name":5,"class":6},1]